Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized Study-Reference-Cited by-同舟云学术

Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized Study

Published:2023-09 Issue:1 Volume:117 Page:74-86
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Chiu Yen-Feng,Liu Tsang-Wu,Shan Yan-Shen,Chen Jen-Shi,Li Chung-Pin,Ho Ching-Liang,Hsieh Ruey-Kuen,Hwang Tsann-Long,Chen Li-Tzong,Ch'ang Hui-Ju

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference47 articles.

1. Pancreatic adenocarcinoma;Ryan;N Engl J Med,2014

2. Adjuvant chemotherapy with fluorouracil plus folinic acid versus gemcitabine following pancreatic cancer resection: A randomized controlled trial;Neoptolemos;JAMA,2010

3. Therapeutic developments in pancreatic cancer: Current and future perspectives;Neoptolemos;Nat Rev Gastroenterol Hepatol,2018

4. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): A multicentre, open-label, randomised, phase 3 trial;Neoptolemos;Lancet,2017

5. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining prognostic value of serum carbohydrate antigen 19-9 and tumor size reduction ratio in pancreatic ductal adenocarcinoma;World Journal of Gastrointestinal Oncology;2024-03-15

2. Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy;Radiation Oncology;2023-08-18